Transition of polycythemia vera to chronic myeloid leukaemia

European Journal of Haematology

Volumn 75, Issue 3, 2005, Pages 264-266

  Saviola, Alessia ^a   Fiorani, Claudia ^a   Ferrara, Leonardo ^a   Mazzocchi, Valeria ^a   Zucchini, Patrizia ^a   Temperani, Paola ^a   Longo, Giuseppe ^a   Emilia, Giovanni ^a,b   Torelli, Giuseppe ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Chronic myeloid leukaemia; Myeloproliferative disorders; Polycythemia vera; Transition

Indexed keywords

ALKYLATING AGENT; BCR ABL PROTEIN; HYDROXYUREA;

ANAMNESIS; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DISEASE ASSOCIATION; FEMALE; HUMAN; PHLEBOTOMY; POLYCYTHEMIA VERA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRASOUND;

AGED; FEMALE; HUMANS; HYDROXYUREA; LEUKEMIA, MYELOID, CHRONIC; POLYCYTHEMIA VERA;

EID: 23844453077     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2005.00488.x     Document Type: Article

References (16)

1. BERK PD, GOLDBERG JD, DONOVAN PB, FRUCHTMAN SM, BERLIN NI, WASSERMAN LR. Therapeutic recommendations in polycythemia vera based on PVSG protocols. Semin Hematol 1986;23:132-143.
2. NAJEAN Y, DESCHAMPS A, DRESCH C, DANIEL MT, RAIN JD, ARRAGO JP. Acute leukemia and myelodysplasia in polycythemia vera: a clinical study with long-term follow-up. Cancer 1988;61:89-95.
3. SPIVAK JL. Polycythemia vera: myths, mechanisms, and management. Blood 2002;100:4272-4290.
4. FINAZZI G, CARUSO V, MARCHIOLI R, et al. for the ECLAP investigators. Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study. Blood 2005;105:2664-2670.
5. LUGASSI G, FARHL R. Chronic neutrophilic leukemia associated with polycythemia vera. Am J Hematol 1989;31:301.
6. FOA P, IURLO A, SAGLIO G, GUERRASIO A, CAPSONI F, MAIOLO AT. Chronic neutrophilic leukaemia associated with polycythemia vera: pathogenetic implications and therapeutic approach. Br J Haematol 1991;78:286-288.
7. HIGUCHI T, OBA R, ENDO M, HARADA H, MORI H, NIIKURA H, OMINE M, FUJITA K. Transition of polycythemia vera to chronic neutrophilic leukemia. Leuk Lymphoma 1999;33:203-206.
8. KEMP NH, STAFFORD H, TANNER R. Chromosome studies during early and terminal chronic myeloid leukaemia. Br Med J 1964;1:1010-1014.
9. KOULISCHER L, FRUHLING J, HENRY J. Observations cytogenetiques dans la maladie de Vaquez. Eur J Cancer 1967;3:193-201.
10. HOPPIN ED, LEWIS JP. Polycythemia rubra vera progressing to Ph-positive chronic myelogenous leukemia. Ann Intern Med 1975;83:820-823.
11. HAQ AU. Transformation of polycythemia vera to Ph-positive chronic myelogenous leukemia. Am J Hematol 1990;35:110-113.
12. JANTUNEN E, NOUSIAINEN T. Ph-positive chronic myelogenous leukemia evolving after polycythemia vera. Am J Hematol 1991;37:212.
13. ROTH AD, ORAL A, PRZEPIORKA D, GOLLIN SM, CHERVENICK PA. Chronic myelogenous leukemia and acute lymphoblastic leukemia occurring in the course of polycythemia vera. Am J Hematol 1993;43:123-128.
14. GANTI AK, POTTI A, MEHDI SA. Chromosomal anomalies in two coexistent myeloproliferative disorders. Cancer Genet Cytogenet 2003;145:172-175.
15. TEFFERI A. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplsia and chronic myelogenous leukemia. Semin Hematol 1999;36(Suppl. 2):3-9.
16. MAURO MJ, LORIAUX M, DEININGER MW. Ph-positive and -negative myeloproliferative syndromes may co-exist. Leukemia 2004;18:1305-1307.